Allarity Therapeutics Current Valuation vs. Price To Book

ALLR Stock  USD 1.11  0.05  4.72%   
Based on Allarity Therapeutics' profitability indicators, Allarity Therapeutics may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in January. Profitability indicators assess Allarity Therapeutics' ability to earn profits and add value for shareholders. As of 12/05/2024, Price To Sales Ratio is likely to drop to 228.54. In addition to that, Days Sales Outstanding is likely to drop to 4,034. At this time, Allarity Therapeutics' Interest Income is relatively stable compared to the past year. As of 12/05/2024, Total Other Income Expense Net is likely to grow to about 5.6 M, while Accumulated Other Comprehensive Income is likely to drop (431.6 K).
For Allarity Therapeutics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Allarity Therapeutics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Allarity Therapeutics utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Allarity Therapeutics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Allarity Therapeutics over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
To learn how to invest in Allarity Stock, please use our How to Invest in Allarity Therapeutics guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allarity Therapeutics. If investors know Allarity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allarity Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(10.98)
Revenue Per Share
(0.02)
Return On Assets
(0.48)
Return On Equity
(1.22)
The market value of Allarity Therapeutics is measured differently than its book value, which is the value of Allarity that is recorded on the company's balance sheet. Investors also form their own opinion of Allarity Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Allarity Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allarity Therapeutics' market value can be influenced by many factors that don't directly affect Allarity Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allarity Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allarity Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allarity Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Allarity Therapeutics Price To Book vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Allarity Therapeutics's current stock value. Our valuation model uses many indicators to compare Allarity Therapeutics value to that of its competitors to determine the firm's financial worth.
Allarity Therapeutics is rated below average in current valuation category among its peers. It is rated below average in price to book category among its peers . As of 12/05/2024, Price To Book Ratio is likely to grow to about (227.3 K). Comparative valuation analysis is a catch-all technique that is used if you cannot value Allarity Therapeutics by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Allarity Current Valuation vs. Competition

Allarity Therapeutics is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 210.26 Million. Allarity Therapeutics has negative current valuation of (12.23 Million) contributing less than 1% to the industry.

Allarity Price To Book vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Allarity Therapeutics

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
(12.23 M)
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Allarity Therapeutics

P/B

 = 

MV Per Share

BV Per Share

 = 
0.36 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Allarity Price To Book Comparison

Allarity Therapeutics is currently under evaluation in price to book category among its peers.

Allarity Therapeutics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Allarity Therapeutics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Allarity Therapeutics will eventually generate negative long term returns. The profitability progress is the general direction of Allarity Therapeutics' change in net profit over the period of time. It can combine multiple indicators of Allarity Therapeutics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-411 K-431.6 K
Net Loss-24.2 M-25.4 M
Income Tax Expense-717 K-752.9 K
Net Interest Income-354 K-371.7 K
Interest Income34.5 K36.2 K
Operating Income-17.9 M-18.8 M
Net Loss-13 M-13.7 M
Income Before Tax-12.6 M-13.2 M
Total Other Income Expense Net5.3 M5.6 M
Net Loss-11.9 M-12.5 M
Non Operating Income Net Other15.2 M13.5 M
Change To Netincome19 M12.7 M
Net Loss(0.01)(0.01)
Income Quality 1.07  0.77 
Net Income Per E B T 0.94  0.69 

Allarity Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Allarity Therapeutics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Allarity Therapeutics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Allarity Therapeutics' important profitability drivers and their relationship over time.

Use Allarity Therapeutics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Allarity Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allarity Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Allarity Therapeutics Pair Trading

Allarity Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Allarity Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Allarity Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Allarity Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Allarity Therapeutics to buy it.
The correlation of Allarity Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Allarity Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Allarity Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Allarity Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Allarity Therapeutics position

In addition to having Allarity Therapeutics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Data Storage Thematic Idea Now

Data Storage
Data Storage Theme
Companies making data storages or providing data storage services. The Data Storage theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Data Storage Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Allarity Stock Analysis

When running Allarity Therapeutics' price analysis, check to measure Allarity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Allarity Therapeutics is operating at the current time. Most of Allarity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Allarity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Allarity Therapeutics' price. Additionally, you may evaluate how the addition of Allarity Therapeutics to your portfolios can decrease your overall portfolio volatility.